tbuckley/cabot-search huggingface dataset:
Survey of Public Health Nursing: Administration and Practice
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Manic syndrome associated with zidovudine
Authors: Frederick W. Schaerf, Robyn Miller, Godfrey D. Pearlson, Michael J. Kaminsky, Debbie Weaver
Journal: JAMA (1988)

<h3>To the Editor.—</h3> We wish to respond to a letter by Maxwell et al<sup>1</sup>in the June 17 issue entitled "Manic Syndrome Associated With Zidovudine Treatment." The authors presented two cases of mania associated with zidovudine therapy. Both patients had either a personal history of affective disorder or a history of a cognitive decline prior to the reported manic episode. We have similarly observed a case of mania precipitated by zidovudine in an individual with the acquired immunodeficiency syndrome dementia complex, as well as a case of major depression occurring less than 24 hours after an increase in zidovudine dosage in a human immunodeficiency virus—seropositive individual with a personal and family history of affective disorder. We wish to emphasize several points concerning psychiatric syndromes in patients receiving zidovudine therapy. First, in such patients who present acutely with manic or depressive symptoms, it is necessary to rule out other
Synthetic Blend for Thyroid Reported
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Wood's Medical and Surgical Monographs.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
QuickStats: Percentage* of U.S. Women Aged 50–74 Years Who Never Had a Mammogram,† by Place of Birth and Length of Residence in the United States§ — National Health Interview Survey, 2013 and 2015¶
Journal: MMWR Morbidity and Mortality Weekly Report (2017)

Department of Health and Human Services/Centers for Disease Control and Prevention * With 95% confidence intervals indicated by error bars.† A mammogram is a radiograph of the breast that might be used to check for breast cancer in women who have no signs or display no symptoms of the disease.The U.S. Preventive Services Task Force recommends screening for breast cancer with mammography every 2 years for women aged 50-74 years.§ Country of birth, number of years residing in the United States, and current age were used to determine nativity and percentage of time in the United States.¶ Estimates are based on household interviews of a sample of the civilian, noninstitutionalized U.S. population and are derived from the National Health Interview Survey.
Contents
Authors: Andrew Schachat, Yan Li, Ou Tan, Robert Brass, Jack Weiss, David Huang, Ming-Tse Kuo, Hsien-Chang Chang, Chao-Kun Cheng, Christopher Henry, Harry Flynn, Darlene Miller, Richard Forster, Eduardo Alfonso, Anna Majander, ¨ivi Lindahl, L Kristiina Vasara, Kari Krootila, Muralidhar Ramappa, Niranjan Pehere, Somasheila Murthy, Sunita Chaurasia, Harsha Rao, Virender Sangwan, Haotian Lin, Weirong Chen, Lixia Luo, Nathan Congdon, Xinyu Zhang, Xiaojian Zhong, Zhaochuan Liu, Wan Chen, Changrui Wu, Danying Zheng, Daming Deng, Shaobi Ye, Zhuoling Lin, Xia Zou, Yizhi Liu, Chixin Du, Meixiao Shen, Ming Li, Dexi Zhu, Michael Wang, Jianhua Wang, Suzanne Van Landingham, Jeffrey Willis, Susan Vitale, Fan Xu, Xin Zhao, Si-Ming Zeng, Li Li, Hai-Bin Zhong, Xiangbin Kong, Mirjam Meltzer, Qianyun Chen, Yangfa Zeng, Yuanzhou Huang, Jian Zhang, Mingguang He, Aparna Ramasubramanian, Carol Shields, Christina Kytasty, Zunair Mahmood, Sanket Shah, Jerry Shields
Journal: Ophthalmology (2012)
Choriocarcinoma in Ibadan, Nigeria: Epidemiologic Aspects&lt;xref ref-type="fn" rid="fn2"&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/xref&gt;
Authors: Junaid, T.A., Hendrickse, J. P. de V., Oladiran, B., Edington, G. M., Williams, A. Olufemi
Journal: JNCI Journal of the National Cancer Institute (1974)

Journal Article Choriocarcinoma in Ibadan, Nigeria: Epidemiologic Aspects Get access T.A. Junaid, T.A. Junaid Search for other works by this author on: Oxford Academic PubMed Google Scholar J. P. de V. Hendrickse, J. P. de V. Hendrickse Search for other works by this author on: Oxford Academic PubMed Google Scholar B. Oladiran, B. Oladiran Search for other works by this author on: Oxford Academic PubMed Google Scholar G. M. Edington, G. M. Edington Search for other works by this author on: Oxford Academic PubMed Google Scholar A. Olufemi Williams A. Olufemi Williams Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 53, Issue 6, December 1974, Pages 1597–1602, https://doi.org/10.1093/jnci/53.6.1597 Published: 01 December 1974 Article history Received: 20 May 1974 Accepted: 14 August 1974 Published: 01 December 1974
In This Issue
Journal: Circulation Research (2010)

Vascular Inflammation, T cells, and Hypertension (p 263)T cells do not instigate hypertension but they make it a whole lot worse, Marvar et al suggest.The team had previously found in mice that T cells are essential mediators of angiotensin II-induced hypertension.Their next question was: How does angiotensin II activate the T cells?Angiotensin II is known to work on the brain, and it has been shown that lesions in the anteroventral third cerebral ventricle prevent angiotensin's hypertensive action.The team found that such lesions also prevented angiotensin-induced T-cell activation.However, the brain lesions did not prevent hypertension and T-cell activation in mice treated with norepinephrine, which works directly on the blood vessels.Together, these results suggest that angiotensin's effect on T cells might be the result of the hypertension itself.The team gave hydralazine-a smooth muscle relaxant and antihypertensive agent-to normal mice treated with angiotensin.Sure enough, T-cell activation was inhibited.Given that T cells not only promote hypertension but also, as shown here, are activated by hypertension, the team suggests a feed forward mechanism whereby T cells add fuel to the growing blood pressure fire.
Thirteenth Training Course on Hormonal Assay Techniques
Journal: Endocrine Reviews (1984)

Journal Article Thirteenth Training Course on Hormonal Assay Techniques Get access Endocrine Reviews, Volume 5, Issue 4, 1 October 1984, Page 552, https://doi.org/10.1210/edrv-5-4-552 Published: 01 October 1984
Spondylolysis
Authors: Robert D. Moreton
Journal: JAMA (1966)

One of the more important developmental anomalies of the lumbar vertebrae, and one which affects the stability of the spinal column, is a failure in ossification of the laminae between the superior and inferior articular processes. This is actually a radiological finding wherein a break is demonstrated in the pars interarticularis or isthmus on one or both sides of the neural arch. When this defect is not associated with a subluxation of the vertebral segment anterior to the lesion, it is usually referred to as spondylolysis. The condition has also been called spondyloschisis, and occasionally the term "prespondylolisthesis" is used to describe the defect. This latter term is unfortunate because it implies the later development of a condition which actually may never take place. I feel that we should report the anatomic variation as it is found and avoid any confusion or unfounded supposition that another pathologic entity may be
Centrosomal Clustering – a Novel Therapeutic Target for Multiple Myeloma.
Authors: Marc S Raab, Iris Breitkreutz, Blanka Rebacz, Thomas O Larsen, Ludmila Wagner, Patrick Hayden, Anthony D. Ho, Mads H Clausen, Hartmut Goldschmidt, Kenneth C. Anderson, Alwin Kraemer
Journal: Blood (2009)
The Golden Complex. A Defence of Inferiority.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diabetes
Authors: Elliott P. Joslin, Leo P. Krall, C. C. Bailey, Howard F. Root, Priscilla White, Alexander Marble
Journal: New England Journal of Medicine (1948)

Pregnancy in DiabetesPregnancy in diabetes continues to interest Dr. Priscilla White,32 and in an article presented before the Third Congress of Obstetrics and Gynecology, her conclusions were brought up to date:The typical course of a diabetic pregnancy as seen in diabetic clinics is the following one: from conception to term the pregnancy has a 50 per cent chance for survival and terminating in a live birth. If pregnancies of diabetics are studied from viability on, the chances for success increase to 65, rarely to 75 per cent. (The expected fetal survival at present is better than 90 per . . .
SOCIETY CONVERSAZIONE.
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Parallel 31: Emerging Trends in NASH
Authors: Salvatore Petta, Vito Marco, Calogero Cammà, Daniela Cabibi, Antonio Craxì, Carlos Pirola, Tomas Fernández Gianotti, Hernán Dopazo, Cristian Rohr, Gustavo Castaño, Silvia Sookoian
Journal: Hepatology (2014)

Background and aims: In Nonalcoholic Fatty Liver Disease (NAFLD), the influence of steatosis on liver stiffness measurement (LSM) is still debated.We assessed the impact of the severity of steatosis on LSM values and on Transient Elastography (TE) accuracy for the diagnosis of liver fibrosis, in a cohort of consecutive patients with NAFLD.Methods: Two hundred fifty-three patients with reliable LSM were assessed by clinical, ultrasonographic and histological (Kleiner score) features.TE was performed using the M probe.Results: Most patients were males (70%), mean age and BMI were respectively 45 years and 29.1 Kg/m2.Diabetes and hypertension were observed in 20% and 24% of patients, respectively.Twenty-eight percent of patients had grade 3 steatosis, one patient on two had F2-F4 fibrosis, and 21% of patients had F3-F4 fibrosis.Among patients with F0-F2 fibrosis, and with F0-F1 fibrosis, mean LSM values, expressed in kPa, were significantly higher in subjects with severe steatosis (≥ 66% at liver biopsy) compared with those without (8.0±3.1 vs 6.5±2.6,p=0.002 for F0-F2; 7.2±6.4vs 6.2±2.2,p=0.04 for F0-F1).Instead no differences were found in patients with F3-F4 and with F2-F4 fibrosis according to the presence of severe steatosis.Accordingly, in subjects without severe fibrosis (F0-F2) and without significant fibrosis (F0-F1), a higher rate of false-positive LSM results was observed in patients with steatosis ≥ 66% compared with those without (F0-F2: 33.3% vs. 13.2%;F0-F1: 23.6% vs. 14.9%).Conclusions: In patients with NAFLD, the presence of severe steatosis lead to an overestimation of liver fibrosis by LSM.In this clinical setting, noninvasive methods correcting LSM values for severity of liver steatosis could improve the performance of TE in predicting fibrosis.
Parallel 17: Hepatitis B: Prevention, Natural History, and Outcomes
Authors: Adrian Di Bisceglie, Manuel Lombardero, Jeffrey Teckman, Lewis Roberts, Harry Janssen, Steven Belle, Jay Hoof- Nagle, Jay Hoofnagle, Gina Choi, Marina Serper, David Kaplan, Kimberly Forde, Gregory Gores, Conatus Lewis, R Roberts
Journal: Hepatology (2015)

Background: HBV infection is frequent world-wide and may result in progressive liver disease or HCC.Effective therapies are available but treatment is usually reserved for patients (pts) with selected biochemical and serological profiles (phenotypes).Currently, criteria for defining HBV phenotype are not standardized and are based upon expert opinion rather than medical evidence.Aim: To determine the distribution of phenotypes in a large cohort of North American pts with chronic HBV infection using standardized definitions and calculation.Methods: Epidemiologic, demographic, biochemical and virologic features of pts enrolled into the HBRN Cohort Study at 19 US and 1 Canadian site were analyzed, assigning pts into 1 of 4 phenotypes: immune tolerant (IT), chronic hepatitis B with (CHB e+) or without HBeAg (CHB e-) or inactive carrier (IC) based upon baseline HBV DNA and ALTs.Cut-off HBV DNA values used to define phenotypes were 10 4 IU/ml for e-negative and 10 5 for e-positive pts.ALT cut-offs were analyzed using either fixed values (30 U/L for men, 20 U/L for women) or using each local lab ULN.Pts not fitting into a phenotype were designated "Indeterminant".Independently, local investigators assigned a phenotype at baseline based on available laboratory values and clinical impression.Results: 1398 adults (51% male, 71% Asian) had data needed to determine phenotype.The table shows the distribution of phenotypes calculated by two methods of assessing ALT and physician assessment.Only moderate agreement was found between clinician-determined and calculated phenotype using fixed ALTs (Kappa 0.39, 95% CI 0.36-0.42).Of note, only 13% of pts were designated Indeterminant by clinicians compared to 20-40% by computer calculation.Using the Fixed ALT groups for comparison, IT was most distinct, being generally younger, more frequently Asian and female.The most frequent clinical phenotype identified was Indeterminant, the majority of whom (83%) had elevated ALT values despite low levels of HBV DNA, not apparently associated with higher BMI, alcohol consumption or HBV genotype.Clinician estimates often differed from the calculated phenotype.Conclusions: The clinical significance of HBV phenotypes using these standardized definitions requires further study based on long term follow up of these patient cohorts but there is clearly a need to re-examine categorization of pts with chronic HBV infection to more accurately predict their outcomes and need for therapy.
Cancer Patients Need Information, Nurses Told
Journal: JNCI Journal of the National Cancer Institute (1988)

Journal Article Cancer Patients Need Information, Nurses Told Get access JNCI: Journal of the National Cancer Institute, Volume 80, Issue 7, 1 June 1988, Page 470, https://doi.org/10.1093/jnci/80.7.470-c Published: 01 June 1988
Sport concussion assessment tool for childrens ages 5 to 12 years
Journal: British Journal of Sports Medicine (2017)

The Child SCAT5 is a standardized tool for evaluating concussions designed for use by physicians and licensed healthcare professionals 1 .If you are not a physician or licensed healthcare professional, please use the Concussion Recognition Tool 5 (CRT5).The Child SCAT5 is to be used for evaluating Children aged 5 to 12 years.For athletes aged 13 years and older, please use the SCAT5.Preseason Child SCAT5 baseline testing can be useful for interpreting post-injury test scores, but not required for that purpose.Detailed instructions for use of the Child SCAT5 are provided on page 7. Please read through these instructions carefully before testing the athlete.Brief verbal instructions for each test are given in italics.The only equipment required for the tester is a watch or timer.This tool may be freely copied in its current form for distribution to individuals, teams, groups and organizations.It should not be altered in any way, re-branded or sold for commercial gain.Any revision, translation or reproduction in a digital form requires specific approval by the Concussion in Sport Group. Recognise and RemoveA head impact by either a direct blow or indirect transmission of force can be associated with a serious and potentially fatal brain injury.If there are significant concerns, including any of the red flags listed in Box 1, then activation of emergency procedures and urgent transport to the nearest hospital should be arranged.
Impact of <i>BRCA1</i>/<i>BRCA2</i> Mutation Testing on Psychologic Distress in a Clinic-Based Sample
Authors: Marc D. Schwartz, Beth N. Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman
Journal: Journal of Clinical Oncology (2002)

PURPOSE: Despite the increasingly widespread availability of BRCA1 and BRCA2 genetic testing, little is known about the psychologic impact of such testing in the clinical setting. The objective of this study was to examine the long-term psychologic impact of receiving BRCA1/2 test results within a clinic-based testing program. PATIENTS AND METHODS: The participants were 279 high-risk women who underwent genetic counseling and testing for alterations in the BRCA1/2 genes. At baseline (before genetic testing) and at 6 months after the disclosure of mutation status, we measured perceived risk for breast and ovarian cancer, cancer-specific distress, and general distress. We examined the impact of the test result on each of these outcomes at the 6-month follow-up. Analyses were conducted separately for probands and their relatives who were unaffected with cancer. RESULTS: We found no effect of test result among affected probands. Among unaffected relatives, we found that participants who received definitive negative test results exhibited significant reductions in perceived risk and distress compared with participants who received positive test results. Importantly, relatives who received positive test results did not exhibit increased distress or perceived risk. CONCLUSION: These results suggest that clinic-based BRCA1/2 testing can lead to psychologic benefits for individuals who receive negative test results. At 6 months after disclosure, those who receive positive or uninformative test results do not exhibit increased psychologic distress or perceived risk.
Update: Pulmonary Hemorrhage/Hemosiderosis Among Infants—Cleveland, Ohio, 1993-1996
Journal: JAMA (2000)

A REVIEW WITHIN CDC AND BY OUTside experts of an investigation of acute pulmonary hemorrhage/hemosiderosis in infants has identified shortcomings in the implementation and reporting of the investigation described in MMWR 1,2 and detailed in other scientific publications authored, in part, by CDC personnel. [3]4][5] The reviews led CDC to conclude that a possible association between acute pulmonary hemorrhage/ hemosiderosis in infants and exposure to molds, specifically Stachybotrys chartarum, commonly referred to by its synonym Stachybotrys atra, was not proven.This report describes the specific findings of these internal and external reviews.